Anti Oxidants to be Showcased at World Conference on Skin Aging

PROTOKINETIX INC. (PKTX: OTCBB)
Vancouver, British Columbia, August 18, 2009

As a follow up to L’Oreal’s independent validation of ProtoKinetix’ patented AAGP™, the Company reports the significance of the upcoming Malta Skin Ageing 2009 conference. This symposium targets researchers, academics, clinicians, pharmaceutical and cosmetic corporations from throughout the world. Such industry giants as L’Oreal and Beiersdorf will be making keynote presentations on the role of anti-oxidants in the prevention of the aging process.

Aging is accelerated by hostile stimuli such as UV, oxygen and toxic chemicals. Anti-oxidants have been proven to be a major defense against these antagonists. The action of AAGP™ has, in turn, been proven to be significantly superior to the benchmark CoQ10 as a protection against oxidative stresses. The mechanism of AAGP™ indicates that it prevents the formation of free radicals which destabilize molecules creating cell damage, cell death, inflammation and premature aging. Dr. Marvin Edeas, Chairman of the Scientific Committee of the Conference states in his letter to colleagues that “Oxidative stress is included in multiple diseases: cancers, Alzheimer diseases, cataract, cardiovascular disease and skin ageing. The use of antioxidants to avoid oxidative stress has been well documented for several years.”

For additional information on the symposium, visit:  www.malta-skinageing.com

As the role of AAGP™ in this arena has been recognized, ProtoKinetix anticipates that more developments will be announced shortly.

About ProtoKinetix
ProtoKinetix Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialog with major corporations and institutions who have contacted the Company about the broad range of applications for AAGP™ products. For more detailed information, visit our website at: www.protokinetix.com

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commission.

Ross L. Senior, President and CEO


Company Office:
ProtoKineitx Inc.
2225 Folkestone Way
West Vancouver, BC
V7S 2X6

Investor Contact
604-926-6627